APA (7th ed.) Citation

Liu, Y., Zhang, Y., Gao, J., Wang, L., Xie, F., Zhang, C., . . . Yan, J. (2025). Venetoclax and hypomethylating agents versus induction chemotherapy for newly diagnosed acute myeloid leukemia patients. BMC Cancer, 25(1), 1. https://doi.org/10.1186/s12885-025-14311-9

Chicago Style (17th ed.) Citation

Liu, Yun, Ying Zhang, Jinhong Gao, Lijuan Wang, Fang Xie, Chengtao Zhang, Peimin Mao, and Jinsong Yan. "Venetoclax and Hypomethylating Agents Versus Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia Patients." BMC Cancer 25, no. 1 (2025): 1. https://doi.org/10.1186/s12885-025-14311-9.

MLA (9th ed.) Citation

Liu, Yun, et al. "Venetoclax and Hypomethylating Agents Versus Induction Chemotherapy for Newly Diagnosed Acute Myeloid Leukemia Patients." BMC Cancer, vol. 25, no. 1, 2025, p. 1, https://doi.org/10.1186/s12885-025-14311-9.